Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,402 public trials 1,306 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

NCT03282474

Conditions
Digestive System Diseases, Hepatitis, Hepatitis Chronic Viral, +6 more
Locations
  • Hannover Medical School, Clinic for Gastroenterology, Hepatology, and Endocrinology Hanover, Lower Saxony, Germany
  • Charité, Campus Virchow-Klinikum, Medical Department, Division of Hepatology and Gastroenterology Berlin, Germany
  • University Medical Center Hamburg-Eppendorf, Center for Internal Medicine, I. Medical Clinic and Polyclinic Hamburg, Germany
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607800

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 93 locations
View Trial Details
Completed

A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment

NCT02387814

Conditions
Digestive System Diseases, Hepatic Insufficiency, Liver Diseases
Locations
  • DaVita Clinical Research Lakewood, Colorado, United States
  • Clinical Pharmacology of Miami (CPMI) Miami, Florida, United States
  • Orlando Clinical Research Center (OCRC) Orlando, Florida, United States
  • Indiana University - Digestive and Liver Diseases Indianapolis, Indiana, United States
View Trial Details
Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

NCT02639247

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 78 locations
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607735

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 86 locations
View Trial Details

Related conditions